Consumer Info
Donnatal Extentabs® have been prescribed by physicians successfully as adjunctive therapy for over 30 years.
Irritable Bowel Syndrome is the:
- Second most frequently encountered diagnosis in clinical practice.1
- Accounts for more physician visits than any symptom except for respiratory tract infections.1
- Most frequent diagnosis made in typical gastroenterologist's practice.1
If you suffer from IBS symptoms - especially from diarrhea and cramping - you may want to ask your healthcare professional about Donnatal Extentabs®.
All Day, All Night... Donnatal Extentabs®
Donnatal Extentabs® are an extended release, combination antispasmodic therapy with a history of trust for over 30 years.
More than 40,000 patient days per year have been prescribed by physicians in the antispasmodic category of therapy since 1991. 2
Of all the options available in this type of therapy, only Donnatal Extentabs provide gradual dissolution over 12 hours, distinctively longer than immediate release tablets. 3
The Benefits of Extended Release
"Extentabs" is an extended release therapy, affording patient convenience day and night with 12-hour dosing.
The nighttime benefit afforded by extended release is important to IBS sufferers whose symptoms occurring through the night prevent a full night's rest. Without proper rest at night, quality of life may be affected as well as the ability to be productive in school or in the workplace.
How Supplied: Donnatal Extentabs® Tablets are supplied as: film coated green, round, compressed tablets printed "P421" in black ink.
Bottles of 100 tablets NDC 66213-0421-10.
Bottles of 500 tablets NDC 66213-0421-50.
There is no generic multisource version of Donnatal Extentabs®.
For stocking assistance, please contact PBM Pharmaceuticals, Inc at the following: jgrenier@pbmpharmaceuticals.com
1) Engstrom, PF, Grossenberg, EB. Diagnosis and Management of Bowel Disease, First Edition, 1999; 2:64. 2) Source Prescription Audit (SPA), Verispan, November 2002. 3) Data on File, PBM Pharmaceuticals.